Novel TLR4 adjuvant elicits protection against homologous and heterologous Influenza A infection.
Vaccine. 2021 Aug 23;39(36):5205-5213. doi: 10.1016/j.vaccine.2021.06.085. Epub 2021 Aug 3.
Vaccine. 2021.
PMID: 34362603